ERF 📈 Eurofins Scientific SE - Overview
Exchange: PA • Country: Luxembourg • Currency: EUR • Type: Common Stock • ISIN: FR0014000MR3
ERF: Testing, Certification, Laboratory, Analytical, Services, Diagnostics
Eurofins Scientific SE is a global leader in providing analytical testing and laboratory services, offering a comprehensive portfolio of methods and tests to assess the safety, identity, composition, and purity of various products. The company's services span multiple industries, including agroscience, where it provides biological assessment, consumer and human safety, environmental safety, product chemistry, and regulatory consultancy, among others. Its agro testing services help ensure the quality and safety of agricultural products, while its assurance services provide product inspection, auditing, certification, and training for the food, consumer products, healthcare, and cosmetics industries.
The company's biopharma and clinical diagnostics services support the development and commercialization of pharmaceuticals and medical devices, while its consumer product testing services help manufacturers ensure compliance with regulatory requirements and industry standards. Eurofins also offers specialized services for the cosmetics and personal care industry, including testing for safety, efficacy, and environmental sustainability. Its environmental testing services cover a range of areas, including water, air, soil, and waste testing, as well as testing for other products such as pesticides and heavy metals. Additionally, the company provides food and feed testing services, including allergen, GMO, and nutritional analysis, to help ensure the safety and quality of food products.
Eurofins' services also extend to audit and certification, training and consulting, food irradiation and labeling, and testing for persistent organic pollutants, veterinary drug residue, and other contaminants. The company's forensic services support law enforcement and legal proceedings, while its genomic services provide DNA analysis and other genetic testing. Eurofins also offers maritime, materials and engineering, and REACH services, among others. With a history dating back to 1987, the company is headquartered in Luxembourg City, Luxembourg, and has established itself as a trusted partner for companies across various industries, providing critical testing and analysis services to support their operations and ensure compliance with regulatory requirements.
As a publicly traded company, Eurofins Scientific SE is listed on the Euronext Paris stock exchange and is classified under the biotechnology sub-industry. Its common stock is traded under the ISIN code FR0014000MR3, and the company's website provides detailed information on its services, history, and operations. With a strong commitment to quality, innovation, and customer satisfaction, Eurofins continues to expand its services and capabilities, supporting the growth and development of various industries worldwide. The company's web presence can be found at https://www.eurofins.com, providing easy access to its range of services and expertise.
Additional Sources for ERF Stock
ERF Stock Overview
Market Cap in USD | 9,427m |
Sector | Healthcare |
Industry | Diagnostics & Research |
GiC Sub-Industry | Biotechnology |
IPO / Inception |
ERF Stock Ratings
Growth 5y | -18.3% |
Fundamental | 59.5% |
Dividend | 37.0% |
Rel. Strength Industry | -546 |
Analysts | - |
Fair Price Momentum | 43.43 EUR |
Fair Price DCF | 120.27 EUR |
ERF Dividends
Dividend Yield 12m | 1.05% |
Yield on Cost 5y | 1.05% |
Annual Growth 5y | 28.27% |
Payout Consistency | 78.0% |
ERF Growth Ratios
Growth Correlation 3m | -43.8% |
Growth Correlation 12m | -65.8% |
Growth Correlation 5y | -29.3% |
CAGR 5y | 0.18% |
CAGR/Mean DD 5y | 0.01 |
Sharpe Ratio 12m | -0.58 |
Alpha | -35.53 |
Beta | 0.57 |
Volatility | 29.18% |
Current Volume | 744.6k |
Average Volume 20d | 363.7k |
As of December 21, 2024, the stock is trading at EUR 47.96 with a total of 744,631 shares traded.
Over the past week, the price has changed by -1.12%, over one month by +4.79%, over three months by -12.48% and over the past year by -17.71%.
Partly, yes. Based on ValueRay Fundamental Analyses, Eurofins Scientific SE (PA:ERF) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 59.51 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ERF as of December 2024 is 43.43. This means that ERF is currently overvalued and has a potential downside of -9.45%.
Eurofins Scientific SE has no consensus analysts rating.
According to ValueRays Forecast Model, ERF Eurofins Scientific SE will be worth about 47.2 in December 2025. The stock is currently trading at 47.96. This means that the stock has a potential downside of -1.58%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 59.5 | 24% |
Analysts Target Price | - | - |
ValueRay Target Price | 47.2 | -1.6% |